Infliximab Substudy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Infliximab Substudy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Infliximab Substudy Today - Breaking & Trending Today

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia

Published: July 10, 2023

This study reports the results of 3 randomized, double-masked, placebo-controlled substudies of abatacept, cenicriviroc, and infliximab plus standard care for C

Source: jamanetwork.com

Related Topics:

United StatesUniversity Of MassachusettsChapel HillTufts Medical CenterWilliam PowderlyAbatacept SubstudyWilliamg PowderlyInfliximab SubstudyCenicriviroc SubstudySegura NunezDanielk Benjamin JrMena LoraDepartment Of HealthUniversity Of KentuckyWashington University In St LouisMerck CoDevelopment AuthorityUniversity Of Washington Medical CenterDepartment Of MedicineTechnical Resources International Biomedical Advanced ResearchRegeneron Pharmaceutical IncUniversity Of Arkansas Medical SciencesRutgers New Jersey Medical SchoolVanderbilt University Medical Center Trial InnovationWashington University School Of Medicine